BIOMARIN PHARMACEUTICAL INC Business Finance Contracts & Agreements

Waiver Letter, dated as of April 11, 2024, by Elliott Investment Management L.P., Elliott Associates, L.P. and Elliott International, L.P., to the Cooperation Agreement, dated as... (Filed With SEC on April 26, 2024)

Asset Purchase Agreement by and between Eli Lilly and Company, BioMarin Pharmaceutical Inc., and BioMarin International Ltd., dated February 8, 2022. Portions of this exhibit have... (Filed With SEC on April 29, 2022)

First Amendment, dated May 28, 2021, to the Credit Agreement by and among BioMarin Pharmaceutical Inc., as the Borrower, Bank of America, N.A., as Administrative Agent, Swing Line... (Filed With SEC on July 30, 2021)

Indenture, dated as of May 14, 2020, by and between BioMarin Pharmaceutical Inc. and U.S. Bank National Association, as Trustee, including the Form of Global Note, representing... (Filed With SEC on May 14, 2020)

Description of Capital Stock (Filed With SEC on February 27, 2020)

BioMarin Pharmaceutical Inc. Amended and Restated 2006 Employee Stock Purchase Plan, as amended and restated April 12, 2019 (Filed With SEC on August 2, 2019)

First Amendment to Credit Agreement dated as of March 15, 2018, by and among BioMarin Pharmaceutical Inc., the lenders party thereto, and Bank of America, N.A. as Administrative... (Filed With SEC on April 27, 2018)

Asset Purchase Agreement by and between Novartis Pharma AG, BioMarin Pharmaceutical Inc. and BioMarin Commercial Ltd., dated as of November 21, 2017 (Filed With SEC on February 26, 2018)

FIRST SUPPLEMENTAL INDENTURE DATED AS OF AUGUST 11, 2017 TO INDENTURE DATED AS OF AUGUST 11, 2017 BETWEEN BIOMARINPHARMACEUTICAL INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION,... (Filed With SEC on August 11, 2017)

BIOMARIN PHARMACEUTICAL INC., Issuer AND WILMINGTON TRUST, NATIONAL ASSOCATION, Trustee INDENTURE Dated as of August 11, 2017 Debt Securities TABLE OF CONTENTS (Filed With SEC on August 11, 2017)

BIOMARIN PHARMACEUTICAL INC. (aDelaware corporation) 0.599% Senior Subordinated Convertible Notes due 2024 UNDERWRITING AGREEMENT (Filed With SEC on August 11, 2017)

BIOMARIN PHARMACEUTICAL INC. (aDelaware corporation) 7,500,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 11, 2016)

ASSET PURCHASE AGREEMENT BY AND BETWEEN BioMarin Pharmaceutical Inc. AND Medivation, Inc. August 21, 2015 ASSET PURCHASE AGREEMENT (Filed With SEC on October 7, 2015)

BIOMARIN PHARMACEUTICAL INC. 2014 Inducement Plan (the Plan) Agreement Regarding Restricted Share Units (Filed With SEC on March 2, 2015)

BIOMARIN PHARMACEUTICAL INC. 2014 Inducement Plan (the Plan) STOCK OPTIONS AGREEMENT (Filed With SEC on March 2, 2015)

BIOMARIN PHARMACEUTICAL INC. (aDelaware corporation) 8,500,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 23, 2015)

ASSET PURCHASE AGREEMENT BY AND BETWEEN REGENERON IRELAND, BIOMARIN PHARMACEUTICAL INC. AND BIOMARIN GALNS LTD. July 29, 2014 ASSET PURCHASE AGREEMENT (Filed With SEC on October 28, 2014)

BIOMARIN PHARMACEUTICAL INC. AMENDED AND RESTATED 2006 EMPLOYEE STOCK. PURCHASE PLAN BIOMARIN PHARMACEUTICAL INC. AMENDED AND RESTATED 2006 EMPLOYEE STOCK PURCHASE PLAN (as... (Filed With SEC on June 10, 2014)

BIOMARIN PHARMACEUTICAL INC. (a Delaware corporation) 1,500,000Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 6, 2014)

CONTRACT OF PURCHASE AND SALE AND JOINT ESCROW INSTRUCTIONS BY AND AMONG SRCORPORATE CENTER PHASE ONE, LLC, A DELAWARE LIMITED LIABILITY COMPANY AND SR CORPORATECENTER PHASE TWO,... (Filed With SEC on February 26, 2014)

SECOND SUPPLEMENTAL INDENTURE DATED AS OF OCTOBER 15, 2013 TO INDENTURE DATED AS OF OCTOBER 15, 2013 BETWEEN BIOMARINPHARMACEUTICAL INC. AND WILMINGTON TRUST, NATIONAL... (Filed With SEC on October 15, 2013)

FIRST SUPPLEMENTAL INDENTURE DATED AS OF OCTOBER 15, 2013 TO INDENTURE DATED AS OF OCTOBER 15, 2013 BETWEEN BIOMARINPHARMACEUTICAL INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION,... (Filed With SEC on October 15, 2013)

BioMarin Pharmaceutical Inc. INDENTURE Dated as ofOctober 15, 2013 Wilmington Trust, National Association, a national banking association, as Trustee TABLE OF CONTENTS (Filed With SEC on October 15, 2013)

BIOMARIN PHARMACEUTICAL INC. (aDelaware corporation) 0.75% Senior Subordinated Convertible Notes due 2018 1.50% Senior Subordinated Convertible Notes due 2020 UNDERWRITING... (Filed With SEC on October 11, 2013)

CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicatedby [****]. Redacted portions filed separately with Confidential Treatment Application. SECOND AMENDMENT TO STOCK... (Filed With SEC on February 26, 2013)

BIOMARIN PHARMACEUTICAL INC. 2012 Inducement Plan (thePlan) Agreement Regarding Restricted Stock Units (Filed With SEC on August 2, 2012)

BIOMARIN PHARMACEUTICAL INC. 2012 Inducement Plan (thePlan) STOCK OPTIONS AGREEMENT (Filed With SEC on August 2, 2012)

CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by[****] Redacted portions filed separately with Confidential Treatment Application. FIRST AMENDMENT TO STOCK... (Filed With SEC on August 2, 2012)

BIOMARIN PHARMACEUTICAL INC. (a Delaware corporation) 6,500,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 1, 2012)

ASSET PURCHASE AGREEMENT (Filed With SEC on February 22, 2012)

CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicatedby [****]. Redacted portions filed separately with Confidential Treatment Application. ASSET PURCHASE AGREEMENT IN... (Filed With SEC on August 1, 2011)

CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by [****]. Redacted portions filed separately with Confidential Treatment Application. STOCK PURCHASE AGREEMENT by... (Filed With SEC on May 3, 2010)

AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 27, 2009)

BIOMARIN PHARMACEUTICAL INC. 1.875% SENIOR SUBORDINATED CONVERTIBLE NOTES DUE 2017 NO. A1 CUSIP: 09061G AD3 (Filed With SEC on April 23, 2007)

SECOND SUPPLEMENTAL INDENTURE Dated as of April 23, 2007 (Filed With SEC on April 23, 2007)

(a Delawarecorporation) 1.875% Senior Subordinated Convertible Notes due 2017 PURCHASE AGREEMENT (Filed With SEC on April 23, 2007)

FIRST AMENDMENT TO PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS (46 Galli Drive Novato, CA) (Filed With SEC on May 4, 2006)

PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS (46 Galli Drive Novato,CA) (Filed With SEC on May 4, 2006)

BioMarin Pharmaceutical Inc. 2.50% Senior Subordinated Convertible Notes due 2013 No. A1 CUSIP: 09061G AC5 (Filed With SEC on March 29, 2006)

FIRST SUPPLEMENTAL INDENTURE Dated as of March 29, 2006 (Filed With SEC on March 29, 2006)

Category

Industry

Companies

Contracts

BIOMARIN PHARMACEUTICAL INC Business Finance Contracts & Agreements